Beam Therapeutics Stock Forecast - Mean Deviation
| BEAM Stock | USD 26.65 1.60 6.39% |
Beam Stock Forecast is based on your current time horizon. Although Beam Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Beam Therapeutics' systematic risk associated with finding meaningful patterns of Beam Therapeutics fundamentals over time.
Beam |
| Check Beam Therapeutics Volatility | Backtest Beam Therapeutics | Information Ratio |
Beam Therapeutics Trading Date Momentum
| On November 25 2024 Beam Therapeutics was traded for 26.65 at the closing time. The top price for the day was 26.90 and the lowest listed price was 25.59 . The trading volume for the day was 1.2 M. The trading history from November 25, 2024 did not affect price variability. The overall trading delta against the current closing price is 2.66% . |
| Compare Beam Therapeutics to competition |
Other Forecasting Options for Beam Therapeutics
For every potential investor in Beam, whether a beginner or expert, Beam Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Beam Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Beam. Basic forecasting techniques help filter out the noise by identifying Beam Therapeutics' price trends.Beam Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Beam Therapeutics stock to make a market-neutral strategy. Peer analysis of Beam Therapeutics could also be used in its relative valuation, which is a method of valuing Beam Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Beam Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Beam Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Beam Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Beam Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Beam Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Beam Therapeutics shares will generate the highest return on investment. By undertsting and applying Beam Therapeutics stock market strength indicators, traders can identify Beam Therapeutics entry and exit signals to maximize returns.
Beam Therapeutics Risk Indicators
The analysis of Beam Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Beam Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting beam stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.12 | |||
| Semi Deviation | 3.59 | |||
| Standard Deviation | 4.28 | |||
| Variance | 18.28 | |||
| Downside Variance | 13.35 | |||
| Semi Variance | 12.86 | |||
| Expected Short fall | (3.67) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Beam Therapeutics to cross-verify your projections. To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam Therapeutics. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.58) | Revenue Per Share 4.273 | Quarterly Revenue Growth (0.17) | Return On Assets (0.09) | Return On Equity (0.18) |
The market value of Beam Therapeutics is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Beam Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam Therapeutics' market value can be influenced by many factors that don't directly affect Beam Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.